Literature DB >> 2733112

Risk factors for perineal seeding of prostate cancer after needle biopsy.

J W Moul1, B J Miles, S J Skoog, D G McLeod.   

Abstract

Between 1975 and 1986, 2,107 perineal prostate biopsies were performed at our institution with 502 (23.8 per cent) positive for prostate cancer. Among this group there were 5 cases (1.0 per cent) of perineal seeding. These 5 cases along with a case referred to our institution represent cases 14 to 19 in the literature. All 19 cases are reviewed to elucidate risk factors for the development of perineal seeding. Biopsy of large volume local tumors appears to be the greatest risk factor associated with 18 of the 19 cases. Technique of biopsy appears to be important in that removal of the Tru-Cut sheath and obturator may expose the perineum to a greater risk of seeding. Other factors discussed include histology, hormonal responsiveness and radiotherapy technique. Distant metastases were discovered simultaneously or within 16 months of the perineal seeding in every case, and all patients died at a median of 36 months after initial diagnosis. Perineal seeding after prostatic needle biopsy is uncommon but its occurrence suggests a poor prognosis.

Entities:  

Mesh:

Year:  1989        PMID: 2733112     DOI: 10.1016/s0022-5347(17)38668-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Transperineal biopsy of the prostate--is this the future?

Authors:  Dwayne T S Chang; Benjamin Challacombe; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2013-09-24       Impact factor: 14.432

2.  Perineal prostatic cancer seeding following Urocut needle biopsy.

Authors:  E Szentgyörgyi
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

3.  Transrectal Ultrasound MRI-Fusion Biopsy of Perirectal Mass.

Authors:  Virginia Li; Elisabeth Mclemore; Vikram Attaluri; Rex Parker; David S Finley
Journal:  J Endourol Case Rep       Date:  2020-12-29

4.  Perineal recurrence of prostate cancer six years after trans-perineal brachytherapy.

Authors:  Wietse Eppinga; Peter Vijverberg; Rien Moerland; Eric Brand; Jochem van der Voort van Zyp; Juus Noteboom; Marco van Vulpen
Journal:  J Contemp Brachytherapy       Date:  2014-11-06

5.  Perineal recurrence of prostate ductal adenocarcinoma after transperineal brachytherapy: a case report and literature review.

Authors:  Takashi Fukagai; Kidai Hirayama; Masashi Morita; Kota Nishimura; Jin Yamatoya; Tetsuo Noguchi; Yu Ogawa; Atsushi Igarashi; Madoka Morota; Masako Kato; Kazuhiko Oshinomi; Yoshio Ogawa; Toyonori Tsuzuki
Journal:  J Contemp Brachytherapy       Date:  2020-12-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.